product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
TBP Antibody
catalog :
8515
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; mouse; fig 2b
Lamonica J, Kwon D, Goffin D, Fenik P, Johnson B, Cui Y, et al. Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome-like phenotypes. J Clin Invest. 2017;127:1889-1904 pubmed publisher
  • western blot; mouse; fig 5b
Ding B, Cave J, Dobner P, Mullikin Kilpatrick D, Bartzokis M, Zhu H, et al. Reciprocal autoregulation by NFI occupancy and ETV1 promotes the developmental expression of dendrite-synapse genes in cerebellar granule neurons. Mol Biol Cell. 2016;27:1488-99 pubmed publisher
  • western blot; human; fig 5f
Hurtado R, Zewdu R, Mtui J, Liang C, Aho R, Kurylo C, et al. Pbx1-dependent control of VMC differentiation kinetics underlies gross renal vascular patterning. Development. 2015;142:2653-64 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.